0001723963-17-000001.txt : 20171129 0001723963-17-000001.hdr.sgml : 20171129 20171129161623 ACCESSION NUMBER: 0001723963-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171129 DATE AS OF CHANGE: 20171129 EFFECTIVENESS DATE: 20171129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BreStem Therapeutics, Inc. CENTRAL INDEX KEY: 0001723963 IRS NUMBER: 821935111 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-299739 FILM NUMBER: 171228510 BUSINESS ADDRESS: STREET 1: 621 HUTTON STREET STREET 2: SUITE 104 CITY: RALEIGH STATE: NC ZIP: 27606 BUSINESS PHONE: 919-513-6157 MAIL ADDRESS: STREET 1: 621 HUTTON STREET STREET 2: SUITE 104 CITY: RALEIGH STATE: NC ZIP: 27606 D 1 primary_doc.xml X0708 D LIVE 0001723963 BreStem Therapeutics, Inc. 621 HUTTON STREET SUITE 104 RALEIGH NC NORTH CAROLINA 27606 919-513-6157 NORTH CAROLINA None None Corporation true 2017 Ke Cheng 621 HUTTON STREET SUITE 104 Raleigh NC NORTH CAROLINA 27606 Executive Officer Director Dongmei Zhu 621 HUTTON STREET SUITE 104 Raleigh NC NORTH CAROLINA 27606 Executive Officer Biotechnology Decline to Disclose 06b false 2017-11-21 false true false 0 2000000 50000 1950000 false 1 0 0 0 None other than payments of salary in the ordinary course of business. false BreStem Therapeutics, Inc. /s/ Tucker A. Idol Tucker A. Idol Attorney-in-Fact 2017-11-29